NIROPHARM is pleased to present to you the new Executive Committee Members of NIROPHARM duly elected in accordance with our constitution as …
Innovation
NIROPHARM (Nigerian Representatives of Overseas Pharmaceutical Manufacturers) members have a distinctive Research and Development orientation and encompasses a wide variety of Pharmaceutical Marketing companies, but all with a common trait of representing one or many overseas pharmaceutical manufacturers
NIROPHARM February 2025 Regulatory Affairs MAnager’s Meeting
NIROPHARM IN THE NEWS
IMPROVE HEALTHCARE
Niropharm member organizations believe in working to improve healthcare indices and take active practical steps to support and be corporately responsible for the health of the citizens in very direct and tangible ways.
ENHANCE QUALITY
Dedicated to working to improve and enhance the quality of service to the Nation, public (local and international) Image, and the scope of the Nigerian Pharmaceutical Industry who face a number of challenges.
TACKLE CHALLENGES
High cost of funds, Poor infrastructure & IPR protection, Chaotic drug distribution, Lack of data for planning, Counterfeiting, Low capacity of Regulatory Agencies, Regulatory Agency, not computerized, Poor surveillance
Advocacy and Support
NIROPHARM advocates and actively supports tangibly, ways to improve the Pharma Sector in Drug Availability, Affordability, Distribution and Quality across the sector
NIROPHARM is the Umbrella Body of Nigerian Representatives of Overseas Pharmaceutical Manufacturers, with a distinctive Research and Development Orientation that encompasses a wide variety of pharmaceutical marketing companies, but all with a common trait of representing one or many overseas pharmaceutical manufacturers.
NIROPHARM is at the forefront of advocating and actively supporting tangibly improvement of the Pharma Sector in Drug Availability, Affordability, Distribution and Quality across the entire Pharma Value Chain. The pharmaceutical market in Nigeria is estimated to reach US\$1,839 million in 2025 (Source: Statista Market Forecast, Nigerian Pharmacies, 2025)
NIROPHARM is responsible for a large percentage of Pharmaceuticals imported into, and in circulation in Nigeria and active in the News Media over issues relevant to the industry. Imports of Pharmaceutical products constitute 70% of the Nigerian Pharma industry, while local Manufacture accounts for the remaining 30%.
